Applying The Fraud-On-The-Market Theory To Research Analysts

Whether and how to apply the fraud-on-the-market theory (i.e., reliance by investors on an alleged misrepresentation is presumed if the company’s shares were traded on an efficient market) to research analyst statements continues to be controversial.

In DeMarco v. Lehman Brothers, 222 F.R.D. 243 (S.D.N.Y. 2004), a case alleging that a Lehman analyst made buy recommendations for RealNetworks, Inc. stock while secretly holding negative views of the stock, Judge Rakoff denied the motion for class certification based on the plaintiffs’ inability to provide sufficient evidence that the fraud-on-the-market theory was applicable. The court noted that there is a “qualitative difference” between a statement of fact from an issuer and a statement of opinion by a research analyst. In particular, a “well-developed efficient market can reasonably be presumed to translate the former into an effect on price, whereas no such presumption attaches to the latter.” As a result, the court held that the fraud-on-the-market doctrine can apply to a case based on research analyst statements “only where the plaintiff can make a prima facie showing that the analyst’s statements materially impacted the market price in a reasonably quantifiable respect.”

Another district judge in the S.D.N.Y., however, has disagreed with that standard and granted class certification in a similar case. In DeMarco v. Robertson Stephens, 2005 WL 12033 (S.D.N.Y. Jan. 20, 2005), Judge Lynch addressed a case alleging that a Robertson Stephens’ analyst and certain corporate officers maintained a buy rating on Corvis Corp. stock while privately selling their own holdings. (An earlier post on the case can be found here). In determining whether the fraud-on-the-market theory could be applicable, the court “decline[d] to adopt a higher standard at class certification for plaintiffs alleging securities fraud by research analysts and their employers.” The court found that “by presenting a mix of market activity evidence, logical arguments, and statistical studies of the influence of at least some analyst statements, plaintiffs have made ‘some showing’ of their ability to make a common legal and factual presentation on reliance to an eventual factfinder.”

The Second Circuit has come close to deciding this issue before, only to be thwarted by a settlement. It may get another chance.

Addition: The New York Law Journal has an article (via law.com – free regist. req’d) on the decision.

Leave a comment

Filed under All The News That's Fit To Blog

TXU Settles

TXU Corp. (NYSE: TXU), a Dallas-based energy company, has announced the preliminary settlement of the securities class action pending against the company in the N.D. of Tex. The case was originally filed in Oct. 2002 and alleges that the company misled investors about its financial performance. The settlement is for $150 million, with at least $66 million to be paid by TXU’s insurers, and also includes certain corporate governance reforms.

Leave a comment

Filed under Settlement

Transcript Of Dura Argument

Did The 10b-5 Daily’s summary of the Dura Pharmaceuticals v. Broudo oral argument get it right? Here’s a chance to find out: the U.S. Supreme Court has posted the transcript. Thanks to Richard Zelichov for pointing out the link.

Leave a comment

Filed under Appellate Monitor

Collecting On Claims

Securities Litigation Watch has an interesting post on the recent series of suits by mutual fund investors alleging that the funds failed to collect as much as $2 billion in securities class action settlement payouts to which the investors were entitled.

Leave a comment

Filed under All The News That's Fit To Blog

Class Action Reform

The U.S. Senate is set to pass the Class Action Fairness Act. The legislation applies some of the reform concepts in the PSLRA and SLUSA to all class actions. Notably, class actions meeting certain jurisdictional criteria would have to be heard in federal court. Reuters reports that the Senate floor debate may take place the week of Feb. 7.

At the same time, proponents of U.S. class action reform are urging France not to permit these types of suits. Jacques Chirac, France’s president, announced earlier this year that he had asked his government to propose legislation allowing collective suits against companies. An article in today’s Financial Times discusses comments made by the president of the U.S. Chamber of Commerce on a trip to Paris, where he warned France that U.S.-style class actions “would damage the economy and shift money from ‘good companies to lawyers.'”

Leave a comment

Filed under All The News That's Fit To Blog

ImClone Settles

ImClone Systems, Inc. (NASDAQ: IMCL), a New York-based biopharmaceutical company, has announced the preliminary settlement of the securities class action pending against the company in the S.D.N.Y. The case was originally filed in 2002 and alleges that the company made false or misleading statements regarding the prospects for FDA approval of its Erbitux cancer drug. The events surrounding the case are probably best known for leading to Martha Stewart’s conviction for lying to federal investigators about her sale of ImClone shares. The settlement is for $75 million.

Leave a comment

Filed under Settlement

Loss Causation And The Research Analyst Cases

The general theme of the research analyst cases is straightforward: the defendants allegedly committed fraud by disseminating research reports that they knew to be overly optimistic. A key question, however, has been whether the subsequent decline in the company’s stock price was caused by the research reports. In an important decision, the U.S. Court of Appeals for the Second Circuit has affirmed the dismissal of two research analyst cases based on the plaintiffs’ failure to adequately plead loss causation.

The appeal was from Judge Pollack’s seminal decision in June 2003 dismissing the securities class actions brought against Merrill Lynch based on allegedly biased research reports concerning 24/7 Real Media, Inc. and Interliant, Inc. Judge Pollack found that the plaintiffs had failed to adequately allege loss causation because there was no alleged connection between the analyst reports and the companies’ financial troubles or the collapse of the overall market. (See this post, among others, for a discussion of the decision.)

In Lentell v. Merrill Lynch & Co., 2005 WL 107044 (2d Cir. Jan. 20, 2005), the Second Circuit affirmed Judge Pollack’s ruling. The court held that to establish loss causation, a plaintiff must allege that the subject of the misrepresentation was the cause of the actual loss suffered. In other words, the misrepresentation must have “concealed something from the market that, when disclosed, negatively affected the value of the security.” In these cases, however, the court found there was “no allegation that the market reacted negatively to a corrective disclosure regarding the falsity of Merrill’s ‘buy’ and ‘accumulate’ recommendations and no allegation that Merrill misstated or omitted risks that did lead to the loss.” Accordingly, the plaintiffs failed to adequately plead loss causation.

The Second Circuit’s decision would appear to have two potential impacts. First, it will make it difficult for the numerous other research analyst cases to go forward. The plaintiffs will need to adequately allege that either: (1) the disclosure of the false recommendations caused a stock price decline; or (2) the recommendations concealed risks about the stocks that later lead to a loss. Certain complaints, however, may satisfy these requirements (see the roundup of cases in this post). Second, the decision could affect the Supreme Court’s pending ruling in the Dura loss causation case. Although the Second Circuit does not alter its previous position on loss causation (rejecting the price inflation theory), the case illustrates the serious impact that loss causation standards can have on securities fraud litigation.

Quote of note: “We are told that Merrill’s ‘buy’ and ‘accumulate’ recommendations were false and misleading, and that the Firm failed to disclose conflicts of interest, salary arrangements, and collusive agreements among analysts, bankers, and 24/7 Media and Interliant. But plaintiffs nowhere explain how or to what extent those misrepresentations and omissions concealed the risk of a significant devaluation of 24/7 Media and Interliant securities. The reports indicate that 24/7 Media and Interliant were high-risk investments, a designation that specifies, inter alia, a ‘high potential for price volatility,’ and ‘no proven track record of earnings.’ And the unchallenged financial analyses presented (e.g., negative EPS ratios and consistent quarterly losses) certainly indicate weakness.”

Addition: The New York Law Journal has an article (via law.com – free regist. req’d) on the decision. Thanks to all of the The 10b-5 Daily’s readers who sent in the opinion.

Leave a comment

Filed under Appellate Monitor

Third Circuit On Confidential Sources

Barred from taking discovery until after a motion to dismiss has been decided, plaintiffs frequently attempt to meet the PSLRA’s heightened pleading standards for securities fraud by citing statements from confidential sources (often former or current employees of the defendant corporation). In its seminal decision in Novak v. Kasaks, the Second Circuit found that it was not necessary to name these confidential sources “provided that they are described in the complaint with sufficient particularity to support the probability that a person in the position occupied by the source would possess the information alleged.”

The Third Circuit has now weighed in on the issue. In California Public Employees’ Retirement System v. The Chubb Corp., 2004 WL 3015578 (3rd Cir. Dec. 30, 2004), the court adopted the Novak standard, but also stated that this standard requires “an examination of the detail provided by the confidential sources, the sources’ basis of knowledge, the reliability of the sources, the corrobative nature of other facts alleged, including from other sources, the coherence and plausibility of the allegations, and similar indicia.” After engaging in this rigorous examination, the court rejected most of the allegations based on confidential sources contained in the complaint. The opinion is notable for its in-depth discussion of different types of confidential sources, including former employees at various levels within Chubb’s corporate organization, and what knowledge reasonably can be imputed to them.

Holding: Dismissal affirmed.

Quote of note: “Citing to a large number of varied sources may in some instance help provide particularity, as when the accounts supplied by the sources corroborate and reinforce one another. In this case, however, the underlying prerequisite – that each source is described sufficiently to support the probability that the source possesses the information alleged – is not met with respect to the overwhelming majority of Plaintiffs’ sources. Cobbling together a litany of inadequate allegations does not render those allegations particularized in accordance with Rule 9(b) or the PSLRA.”

Leave a comment

Filed under Appellate Monitor

Cabletron Settles

One of the longest-running securities class actions has settled. The case against Cabletron Systems, Inc. was originally filed in the D. of N.H. in 1997. The plaintiffs alleged that the company hid problems with its main products and engaged in accounting fraud.

In a remarkable series of events, the case was dismissed in 1998 with leave to amend, reassigned several times after the original judge passed away, dismissed again in 2001, reinstated by the U.S. Court of Appeals for the First Circuit in 2002 (in a well-known opinion), and has since been bogged down in discovery and procedural disagreements. In the interim, Cabletron has been replaced with a successor company, Enterasys Networks, which is settling the suit.

According to Enterasys’ announcement, the preliminary settlement is for $10.5 million. All but $500,000 of that amount is expected to come from the proceeds of certain insurance policies. This is the second securities class action Enterasys has settled in the last fifteen months.

Leave a comment

Filed under Settlement

PLI Telephone Briefing On Pleading Scienter

The Private Securities Litigation Reform Act of 1995 requires plaintiffs alleging securities fraud to plead a “strong inference” of scienter (i.e., fraudulent intent) on the part of the defendants to survive a motion to dismiss. Exactly how to apply this standard, however, has been the subject of constant litigation. Recent notable judicial decisions have addressed, among other topics, what is necessary to adequately plead the scienter of a corporate defendant, the use of control person liability, and the role of insider stock sales in establishing a motive to commit fraud.

The author of The 10b-5 Daily, Lyle Roberts (Wilson Sonsini Goodrich & Rosati), will be chairing a Practising Law Institute telephone briefing on this topic on Thursday, January 20 at 1 p.m. ET. The panelists are Sam Rudman (Lerach Coughlin Stoia Geller Rudman & Robbins) and Bruce Carton (Executive Director, Securites Class Action Services, Institutional Shareholder Services). CLE credit is available. Click here to register.

Leave a comment

Filed under All The News That's Fit To Blog